HOOKIPA Pharma Inc

(NASDAQ:HOOK)

Latest On HOOKIPA Pharma Inc (HOOK):

Date/Time Type Description Signal Details
2023-05-11 20:40 ESTNewsHOOKIPA Pharma GAAP EPS of -$0.27 misses by $0.03, revenue of $3.17M misses by $1.34MN/A
2023-04-26 18:30 ESTNewsHookipa gains on upcoming presentation on cancer drugN/A
2023-04-18 23:49 ESTNewsHookipa Pharma: A Speculative Biotech Worthy Of A Spot On My Watch ListN/A
2023-03-16 03:34 ESTNewsHOOKIPA Pharma Inc. (HOOK) Q4 2022 Earnings Call TranscriptN/A
2023-03-15 12:14 ESTNewsHOOKIPA Pharma GAAP EPS of -$0.17 beats by $0.04, revenue of $7.83M beats by $4.56MN/A
2023-03-14 21:25 ESTNewsHOOKIPA Pharma Q4 2022 Earnings PreviewN/A
2023-02-13 21:02 ESTNewsHookipa Pharma gets $10M milestone payment from RocheN/A
2023-01-04 20:12 ESTNewsHOOKIPA Pharma achieves $5M milestone payment under collaboration with GileadN/A
2022-12-15 10:41 ESTNewsHookipa Pharma promotes Katia Schlienger to chief medical officerN/A
2022-11-14 09:54 ESTNewsHOOKIPA Pharma GAAP EPS of -$0.25 beats by $0.02, revenue of $2.23M misses by $0.68MN/A
2022-10-20 17:20 ESTNewsHookipa stock surges 46% on license deal with Roche for immunotherapyN/A
2022-08-17 19:21 ESTNewsHOOKIPA Pharma (HOOK) August-2022-Investor-PresentationN/A
2022-08-11 10:34 ESTNewsHOOKIPA Pharma GAAP EPS of -$0.23 beats by $0.14, revenue of $2.75M misses by $0.61MN/A
2022-07-25 14:30 ESTNewsHOOKIPA wins FDA nod to start clinical studies for prostate cancer therapyN/A
2022-06-04 02:21 ESTNewsHookipa posts positive preclinical data from arenaviral HIV therapeutic vaccines trialN/A
2022-05-21 07:04 ESTNewsHOOKIPA Pharma (HOOK) Investor Presentation - SlideshowN/A
2022-05-16 13:14 ESTNewsHOOKIPA Pharma GAAP EPS of -$0.40 misses by $0.19, revenue of $1.44M misses by $13.09MN/A
2022-05-02 21:15 ESTNewsHOOKIPA Pharma promotes business chief to COO roleN/A
2022-04-13 18:27 ESTNewsHookipa stock rises 12% on pre-clinical data related to cancer drug platformN/A
2022-03-30 02:32 ESTNewsHookipa: Speculative Biotech With Key Catalysts In 2022N/A
2022-03-24 13:28 ESTNewsHOOKIPA Pharma GAAP EPS of -$0.65 misses by $0.03, revenue of $3.9M beats by $0.11MN/A
2022-03-24 13:27 ESTNewsHOOKIPA Pharma Inc. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-03-24 13:27 ESTNewsHOOKIPA Pharma Inc. (HOOK) CEO Joern Aldag on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-23 03:36 ESTNewsHoopika Pharma promotes internal candidate to Chief Scientific Officer roleN/A
2022-03-02 18:23 ESTNewsHOOKIPA Pharma slumps 15% on pricing $75M stock and preferred stock offeringN/A
2022-03-02 01:58 ESTNewsHookipa Pharma slips on equity offeringN/A
2022-02-28 11:50 ESTNewsWatch these five stocks for short squeeze potentialN/A
2022-02-27 17:20 ESTNewsSA readers grab Inspirato, HOOKIPA and megacaps; merger deal pushes them away from BDSIN/A
2022-02-16 01:42 ESTNewsHOOKIPA Pharma gains 51% after hours on amended agreement with GileadN/A
2022-01-18 22:11 ESTNewsHOOKIPA HB-200 drug combo gets FDA fast track status for head, neck cancerN/A
2021-11-10 09:31 ESTNewsHOOKIPA Pharma EPS misses by $0.05, misses on revenueN/A
2021-10-15 15:29 ESTNewsWarning: HOOK is at high risk of performing badlyN/A
2021-10-14 19:26 ESTNewsHOOKIPA highlights benefits of arenaviral immunotherapy in fighting cancerN/A
2021-09-29 16:47 ESTNewsWarning: HOOK has been downgraded to Very BearishN/A
2021-09-21 20:26 ESTNewsHookipa collaborates with Merck to evaluate HB-200/Keytruda combo in head and neck cancersN/A
2021-08-12 18:26 ESTNewsHOOKIPA Pharma EPS beats by $0.06, beats on revenueN/A
2021-07-21 11:31 ESTNewsHookipa Pharma's HB-200 shows "positive" clinical efficacy in HPV16+ cancersN/A
2021-07-21 11:30 ESTNewsHOOKIPA nears five-month low as SVB Leerink expects near-term pressureN/A
2021-07-21 11:19 ESTNewsChecking Back In On HOOKIPA PharmaN/A
2021-07-21 11:17 ESTNewsHOOKIPA Pharma (HOOK) Investor Presentation -SildeshowN/A
2021-03-18 20:13 ESTNewsHOOKIPA Pharma EPS beats by $0.13, beats on revenueN/A
2021-03-18 20:12 ESTNewsHOOKIPA Pharma shares up after Q4 beatN/A
2021-03-18 20:11 ESTNewsHOOKIPA Pharma Inc. (HOOK) CEO Joern Aldag on Q4 2020 Results - Earnings Call TranscriptN/A
2021-01-07 07:52 ESTAnalyst RatingThe Analyst Target Price has increased from $21.86 to $22.29.Buy
2020-12-31 16:57 ESTNewsHookipa: Data Readouts Of 2021's HB-101, HB-201, And HB-201/-202 Hold Promising UpsideN/A
2020-12-09 19:20 ESTNewsHOOKIPA Pharma prices public offering of common stock and preferred stockN/A
2020-12-09 01:19 ESTNewsHOOKIPA Pharma proposes public offering of common and preferred stockN/A
2020-12-08 12:00 ESTAnalyst RatingThe Analyst Target Price has increased from $20.86 to $21.86.Buy
2020-12-01 19:43 ESTNewsHookipa CMV vaccine shows positive effect in mid-stage studyN/A
2020-12-01 12:10 ESTAnalyst RatingThe Analyst Target Price has increased from $19 to $20.86.Buy

About HOOKIPA Pharma Inc (HOOK):

HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immune-therapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in preclinical studies for the treatment of human papillomavirus-positive cancers. The company has a collaboration with Gilead Sciences, Inc. to develop infectious disease product candidates intended to support functional cures for chronic Hepatitis B virus and human immunodeficiency virus infections. HOOKIPA Pharma Inc. was founded in 2011 and is headquartered in New York, New York.

HOOK Quotes by TradingView

See Advanced Chart

General

  • Name HOOKIPA Pharma Inc
  • Symbol HOOK
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 85
  • Fiscal Year EndDecember
  • IPO Date2019-04-18
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Web URLhttp://www.hookipapharma.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 16.81
  • Price/Book (Most Recent Quarter) 3.8
  • Enterprise Value Revenue 15.45
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.47
  • Profit Margin -232%
  • Operating Margin -284%
  • Return on Assets -23%
  • Return on Equity -38%
  • Revenue 18.04 million
  • Earnings Per Share -$4.91
  • Revenue Per Share $0.7
  • Gross Profit -34370000
  • Quarterly Earnings Growth 98.2%
View More

Highlights

  • Market Capitalization 391.05 million
  • EBITDA -30286000
  • PE Ratio -1.04
  • Analyst Target Price $22.29
  • Book Value Per Share $3.59
View More

Share Statistics

  • Shares Outstanding 25.76 million
  • Shares Float 14.38 million
  • % Held by Insiders 1132%
  • % Held by Institutions 47.29%
  • Shares Short 1.29 million
  • Shares Short Prior Month 1.3 million
  • Short Ratio 8.3
  • Short % of Float 7%
  • Short % of Shares Outstanding 4%
View More

Technicals

  • 52 Week High $13.7
  • 52 Week Low $7.07
  • 50 Day Moving Average 11.85
  • 200 Day Moving Average 11
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

HOOKIPA Pharma Inc (HOOK) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

HOOKIPA Pharma Inc (HOOK) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-12$4.04 million-$0.53-$0.41-29.27%
2020-06-302020-08-13$N/A-$0.28-$0.4436.84%
2020-03-312020-05-14$3.7 million-$0.43-$0.5013.13%
2019-12-312020-03-19$3.62 million-$0.40-$0.5932.2%
2019-09-302019-11-12$2.04 million-$0.45-$0.6328.85%
2019-06-302019-08-12$4.05 million-$0.63-$0.51-23.53%
2019-03-312019-05-20$2.24 million-$0.43-$0.40-7.5%

HOOKIPA Pharma Inc (HOOK) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

HOOKIPA Pharma Inc (HOOK) Chart:

HOOKIPA Pharma Inc (HOOK) News:

Below you will find a list of latest news for HOOKIPA Pharma Inc (HOOK) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

HOOKIPA Pharma Inc (HOOK) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-01-172.50.1CALL0 0119.85TRUE00
2025-01-1750.69CALL0 595.76FALSE00
2025-01-177.50.51CALL0 200FALSE00
2025-01-17101.35CALL0 340FALSE00
2025-01-1712.50.8CALL0 10FALSE00
2025-01-172.50.1PUT0 30FALSE00
2025-01-1751.17PUT0 386.34TRUE00
2025-01-177.50PUT0 0104.85TRUE00
2025-01-17100PUT0 0178.13TRUE00
2025-01-1712.50PUT0 0188.21TRUE00
2025-04-172.50CALL0 0111.91TRUE00
2025-04-1750.5CALL1 0103.27FALSE0.50
2025-04-177.51.25CALL0 20FALSE00
2025-04-172.50PUT0 00FALSE00
2025-04-1750PUT0 093.46TRUE00
2025-04-177.53.3PUT0 181.45TRUE00

Latest HOOK Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST62$1.66
Jun 13, 2022 7:59 PM EST124$1.66
Jun 13, 2022 7:59 PM EST62$1.66
Jun 13, 2022 7:59 PM EST15$1.66
Jun 13, 2022 7:59 PM EST14$1.65

HOOKIPA Pharma Inc (HOOK) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920079717/0001104659-20-079717-index.htm
2019-02-11UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1760542/000000000019001884/0000000000-19-001884-index.htm
2020-05-29UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1760542/000000000020004792/0000000000-20-004792-index.htm
2018-12-14DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1760542/000091205718000521/0000912057-18-000521-index.htm
2019-01-17DRS/ADraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1760542/000091205719000020/0000912057-19-000020-index.htm
2019-02-26DRS/ADraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1760542/000091205719000065/0000912057-19-000065-index.htm
2019-03-22S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1760542/000104746919001538/0001047469-19-001538-index.htm
2019-04-08S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1760542/000104746919002035/0001047469-19-002035-index.htm
2019-04-19424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1760542/000104746919002394/0001047469-19-002394-index.htm
2020-04-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1760542/000104746920002646/0001047469-20-002646-index.htm
2020-05-15S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1760542/000104746920003099/0001047469-20-003099-index.htm
2019-04-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1760542/000110465919021117/0001104659-19-021117-index.htm
2019-04-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1760542/000110465919021118/0001104659-19-021118-index.htm
2019-04-158-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1760542/000110465919021347/0001104659-19-021347-index.htm
2019-04-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465919022004/0001104659-19-022004-index.htm
2019-04-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465919022005/0001104659-19-022005-index.htm
2019-04-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465919022006/0001104659-19-022006-index.htm
2019-04-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465919022007/0001104659-19-022007-index.htm
2019-04-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465919022008/0001104659-19-022008-index.htm
2019-04-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465919022009/0001104659-19-022009-index.htm
2019-04-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465919022010/0001104659-19-022010-index.htm
2019-04-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465919022011/0001104659-19-022011-index.htm
2019-04-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465919022012/0001104659-19-022012-index.htm
2019-04-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465919022013/0001104659-19-022013-index.htm
2019-04-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465919022014/0001104659-19-022014-index.htm
2019-04-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465919022015/0001104659-19-022015-index.htm
2019-04-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465919022016/0001104659-19-022016-index.htm
2019-04-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465919022018/0001104659-19-022018-index.htm
2019-04-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465919022019/0001104659-19-022019-index.htm
2019-04-18FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1760542/000110465919022044/0001104659-19-022044-index.htm
2019-04-23S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1760542/000110465919023110/0001104659-19-023110-index.htm
2019-04-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1760542/000110465919023112/0001104659-19-023112-index.htm
2019-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465919023443/0001104659-19-023443-index.htm
2019-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465919023444/0001104659-19-023444-index.htm
2019-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465919023448/0001104659-19-023448-index.htm
2019-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465919023450/0001104659-19-023450-index.htm
2019-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465919023451/0001104659-19-023451-index.htm
2019-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465919023452/0001104659-19-023452-index.htm
2019-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465919023453/0001104659-19-023453-index.htm
2019-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465919023454/0001104659-19-023454-index.htm
2019-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465919023455/0001104659-19-023455-index.htm
2019-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465919023468/0001104659-19-023468-index.htm
2019-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465919023469/0001104659-19-023469-index.htm
2019-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465919023470/0001104659-19-023470-index.htm
2019-04-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465919023694/0001104659-19-023694-index.htm
2019-04-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465919023695/0001104659-19-023695-index.htm
2019-05-03SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1760542/000110465919026802/0001104659-19-026802-index.htm
2019-08-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1760542/000110465919045303/0001104659-19-045303-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1760542/000110465919062606/0001104659-19-062606-index.htm
2019-11-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465919065358/0001104659-19-065358-index.htm
2019-12-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465919071850/0001104659-19-071850-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465919074342/0001104659-19-074342-index.htm
2019-12-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465919075319/0001104659-19-075319-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920000850/0001104659-20-000850-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920000851/0001104659-20-000851-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920000852/0001104659-20-000852-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920000853/0001104659-20-000853-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920000856/0001104659-20-000856-index.htm
2020-01-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920004735/0001104659-20-004735-index.htm
2020-01-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920005577/0001104659-20-005577-index.htm
2020-01-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920007181/0001104659-20-007181-index.htm
2020-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920009230/0001104659-20-009230-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920021312/0001104659-20-021312-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920021820/0001104659-20-021820-index.htm
2020-03-19S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920035912/0001104659-20-035912-index.htm
2020-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920050690/0001104659-20-050690-index.htm
2020-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920050691/0001104659-20-050691-index.htm
2020-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920050692/0001104659-20-050692-index.htm
2020-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920050694/0001104659-20-050694-index.htm
2020-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920050695/0001104659-20-050695-index.htm
2020-04-28DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1760542/000110465920052407/0001104659-20-052407-index.htm
2020-05-22CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1760542/000110465920065329/0001104659-20-065329-index.htm
2020-06-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1760542/000110465920074961/0001104659-20-074961-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920075252/0001104659-20-075252-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920075253/0001104659-20-075253-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920075254/0001104659-20-075254-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920075255/0001104659-20-075255-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920075257/0001104659-20-075257-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920075259/0001104659-20-075259-index.htm
2020-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920075260/0001104659-20-075260-index.htm
2020-06-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1760542/000110465920075441/0001104659-20-075441-index.htm
2020-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920079717/0001104659-20-079717-index.htm
2020-07-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920085605/0001104659-20-085605-index.htm
2020-07-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920085606/0001104659-20-085606-index.htm
2020-07-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920085607/0001104659-20-085607-index.htm
2020-07-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920085609/0001104659-20-085609-index.htm
2020-07-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920085611/0001104659-20-085611-index.htm
2020-07-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920085613/0001104659-20-085613-index.htm
2020-07-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920085615/0001104659-20-085615-index.htm
2020-07-244/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920086507/0001104659-20-086507-index.htm
2020-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920106098/0001104659-20-106098-index.htm
2020-10-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920112628/0001104659-20-112628-index.htm
2020-10-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1760542/000110465920116083/0001104659-20-116083-index.htm
2020-10-233Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920117702/0001104659-20-117702-index.htm
2020-10-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920117703/0001104659-20-117703-index.htm
2020-10-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920117704/0001104659-20-117704-index.htm
2020-10-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920117706/0001104659-20-117706-index.htm
2020-10-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920117707/0001104659-20-117707-index.htm
2020-10-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920117708/0001104659-20-117708-index.htm
2020-10-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920117709/0001104659-20-117709-index.htm
2020-10-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000110465920117710/0001104659-20-117710-index.htm
2019-04-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000114420419020101/0001144204-19-020101-index.htm
2019-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000114420419020978/0001144204-19-020978-index.htm
2019-04-24SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1760542/000114420419020980/0001144204-19-020980-index.htm
2019-04-30SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1760542/000114420419022533/0001144204-19-022533-index.htm
2019-04-26SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1760542/000119312519122487/0001193125-19-122487-index.htm
2019-05-03SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1760542/000119312519136927/0001193125-19-136927-index.htm
2020-02-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1760542/000119312520031499/0001193125-20-031499-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1760542/000119312520035565/0001193125-20-035565-index.htm
2019-04-16CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1760542/000135445719000208/0001354457-19-000208-index.htm
2019-02-26DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1760542/000141057819000101/0001410578-19-000101-index.htm
2019-05-2010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1760542/000155837019005207/0001558370-19-005207-index.htm
2019-08-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1760542/000155837019007983/0001558370-19-007983-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1760542/000155837019010815/0001558370-19-010815-index.htm
2020-03-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1760542/000155837020002917/0001558370-20-002917-index.htm
2020-03-1910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1760542/000155837020002928/0001558370-20-002928-index.htm
2020-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1760542/000155837020006551/0001558370-20-006551-index.htm
2020-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1760542/000155837020006554/0001558370-20-006554-index.htm
2020-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1760542/000155837020010485/0001558370-20-010485-index.htm
2020-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1760542/000155837020010487/0001558370-20-010487-index.htm
2019-04-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000163859919000431/0001638599-19-000431-index.htm
2019-04-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000163859919000432/0001638599-19-000432-index.htm
2019-02-27DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1760542/000176054219000001/0001760542-19-000001-index.htm
2019-04-17EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1760542/999999999519000742/9999999995-19-000742-index.htm
2020-05-27EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1760542/999999999520001260/9999999995-20-001260-index.htm
2019-04-18CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1760542/999999999719002713/9999999997-19-002713-index.htm

HOOKIPA Pharma Inc (HOOK) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of HOOKIPA Pharma Inc (HOOK). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1132%
Institutional Ownership: 4729%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-01-23Anders LiljaSr. VP, Technical DevelopmentSell4,075.0012.1749,601.310.00https://www.sec.gov/Archives/edgar/data/1760542/000110465920007181/0001104659-20-007181-index.htm
2020-01-23Anders LiljaSr. VP, Technical DevelopmentSell7,568.0012.8196,931.700.00https://www.sec.gov/Archives/edgar/data/1760542/000110465920007181/0001104659-20-007181-index.htm
2020-01-14Klaus OrlingerSr. VP, ResearchSell8,500.0011.3096,052.550.00https://www.sec.gov/Archives/edgar/data/1760542/000110465920004735/0001104659-20-004735-index.htm
2020-01-16Klaus OrlingerSr. VP, ResearchSell1,711.0011.5619,781.210.00https://www.sec.gov/Archives/edgar/data/1760542/000110465920005577/0001104659-20-005577-index.htm
2020-01-21Klaus OrlingerSr. VP, ResearchSell6,789.0012.0281,591.560.00https://www.sec.gov/Archives/edgar/data/1760542/000110465920005577/0001104659-20-005577-index.htm
2020-01-16Klaus OrlingerSr. VP, ResearchBuy1,140.000.10114.001,140.00https://www.sec.gov/Archives/edgar/data/1760542/000110465920005577/0001104659-20-005577-index.htm
2020-07-20Klaus OrlingerEVP, ResearchBuy1,216.001,216.00https://www.sec.gov/Archives/edgar/data/1760542/000110465920085609/0001104659-20-085609-index.htm
2020-01-16Klaus OrlingerSr. VP, ResearchBuy571.000.1057.101,711.00https://www.sec.gov/Archives/edgar/data/1760542/000110465920005577/0001104659-20-005577-index.htm
2020-07-20Roman NecinaChief Technology OfficerBuy1,984.001,984.00https://www.sec.gov/Archives/edgar/data/1760542/000110465920085611/0001104659-20-085611-index.htm
2020-07-20Reinhard KanderaChief Financial OfficerBuy2,036.002,036.00https://www.sec.gov/Archives/edgar/data/1760542/000110465920085607/0001104659-20-085607-index.htm
2020-10-21Deventer Sander vanDirectorBuy2,485.002,485.00https://www.sec.gov/Archives/edgar/data/1760542/000110465920117709/0001104659-20-117709-index.htm
2019-04-23Capital Fund II Cooperatief U.A. Forbion10% Share HolderBuy53,571.0014.00749,994.002,494,173.00https://www.sec.gov/Archives/edgar/data/1760542/000110465919023695/0001104659-19-023695-index.htm
2020-10-02CAPITAL VI FCPR SOFINNOVA10% Share HolderSell300.0010.003,000.003,906,194.00https://www.sec.gov/Archives/edgar/data/1760542/000110465920112628/0001104659-20-112628-index.htm
2020-09-15CAPITAL VI FCPR SOFINNOVA10% Share HolderSell9,261.0013.16121,912.733,906,494.00https://www.sec.gov/Archives/edgar/data/1760542/000110465920106098/0001104659-20-106098-index.htm
2020-09-15CAPITAL VI FCPR SOFINNOVA10% Share HolderSell32,336.0012.45402,563.803,915,755.00https://www.sec.gov/Archives/edgar/data/1760542/000110465920106098/0001104659-20-106098-index.htm
2020-07-20CAPITAL VI FCPR SOFINNOVA10% Share HolderSell12,483.0011.94149,101.953,948,091.00https://www.sec.gov/Archives/edgar/data/1760542/000110465920085613/0001104659-20-085613-index.htm
2020-06-29CAPITAL VI FCPR SOFINNOVA10% Share HolderSell3,280.0011.7838,627.583,960,574.00https://www.sec.gov/Archives/edgar/data/1760542/000110465920079717/0001104659-20-079717-index.htm
2019-04-23CAPITAL VI FCPR SOFINNOVA10% Share HolderBuy357,142.0014.004,999,988.003,963,854.00https://www.sec.gov/Archives/edgar/data/1760542/000110465919023694/0001104659-19-023694-index.htm
2020-01-23Anders LiljaSr. VP, Technical DevelopmentBuy4,075.000.10407.504,075.00https://www.sec.gov/Archives/edgar/data/1760542/000110465920007181/0001104659-20-007181-index.htm
2020-07-20Jorn AldagChief Executive OfficerBuy4,128.004,128.00https://www.sec.gov/Archives/edgar/data/1760542/000110465920085605/0001104659-20-085605-index.htm
2019-12-17Igor MatushanskyChief Medical OfficerSell11,484.007.8790,379.0843,411.00https://www.sec.gov/Archives/edgar/data/1760542/000110465919074342/0001104659-19-074342-index.htm
2020-10-21David Ross KaufmanDirectorBuy4,577.004,577.00https://www.sec.gov/Archives/edgar/data/1760542/000110465920117706/0001104659-20-117706-index.htm
2020-10-21Christoph LengauerDirectorBuy4,603.004,603.00https://www.sec.gov/Archives/edgar/data/1760542/000110465920117707/0001104659-20-117707-index.htm
2020-10-21Graziano SeghezziDirectorBuy4,708.004,708.00https://www.sec.gov/Archives/edgar/data/1760542/000110465920117710/0001104659-20-117710-index.htm
2019-12-19Igor MatushanskyChief Medical OfficerBuy6,000.000.10600.0049,411.00https://www.sec.gov/Archives/edgar/data/1760542/000110465919075319/0001104659-19-075319-index.htm
2020-10-21Julie O'NeillDirectorBuy4,969.004,969.00https://www.sec.gov/Archives/edgar/data/1760542/000110465920117708/0001104659-20-117708-index.htm
2020-01-29Igor MatushanskyChief Medical OfficerSell5,500.0012.7369,992.4553,398.00https://www.sec.gov/Archives/edgar/data/1760542/000110465920009230/0001104659-20-009230-index.htm
2019-12-17Igor MatushanskyChief Medical OfficerBuy26,312.000.102,631.2054,895.00https://www.sec.gov/Archives/edgar/data/1760542/000110465919074342/0001104659-19-074342-index.htm
2020-07-20Igor MatushanskyChief Medical OfficerBuy2,736.0056,134.00https://www.sec.gov/Archives/edgar/data/1760542/000110465920085606/0001104659-20-085606-index.htm
2020-10-21Michael Aaron KellyDirectorBuy5,754.005,754.00https://www.sec.gov/Archives/edgar/data/1760542/000110465920117704/0001104659-20-117704-index.htm
2019-12-19Igor MatushanskyChief Medical OfficerSell10,404.009.93103,311.7258,898.00https://www.sec.gov/Archives/edgar/data/1760542/000110465919075319/0001104659-19-075319-index.htm
2020-01-21Klaus OrlingerSr. VP, ResearchBuy6,789.000.10678.906,789.00https://www.sec.gov/Archives/edgar/data/1760542/000110465920005577/0001104659-20-005577-index.htm
2019-12-19Igor MatushanskyChief Medical OfficerBuy19,891.000.101,989.1069,302.00https://www.sec.gov/Archives/edgar/data/1760542/000110465919075319/0001104659-19-075319-index.htm
2019-04-23BROS. ADVISORS LP BAKERInsiderBuy72,128.0014.001,009,792.0072,128.00https://www.sec.gov/Archives/edgar/data/1760542/000163859919000432/0001638599-19-000432-index.htm
2020-01-14Klaus OrlingerSr. VP, ResearchBuy7,358.000.10735.807,358.00https://www.sec.gov/Archives/edgar/data/1760542/000110465920004735/0001104659-20-004735-index.htm
2020-01-23Anders LiljaSr. VP, Technical DevelopmentBuy7,568.000.10756.807,568.00https://www.sec.gov/Archives/edgar/data/1760542/000110465920007181/0001104659-20-007181-index.htm
2019-04-23BROS. ADVISORS LP BAKERInsiderBuy820,729.0014.0011,490,206.00820,729.00https://www.sec.gov/Archives/edgar/data/1760542/000163859919000432/0001638599-19-000432-index.htm
2020-01-14Klaus OrlingerSr. VP, ResearchBuy1,142.000.10114.208,500.00https://www.sec.gov/Archives/edgar/data/1760542/000110465920004735/0001104659-20-004735-index.htm
2020-10-21de Winkel Jan vanDirectorBuy9,153.009,153.00https://www.sec.gov/Archives/edgar/data/1760542/000110465920117703/0001104659-20-117703-index.htm